
|Podcasts|June 14, 2023
Generational Perspectives in Multiple Sclerosis Care
Listen
0:00 / 0:00
Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.
Advertisement
2:00 MS as a previously untreatable disease and evolution of DMTs
5:49 Progress in treating MS
8:18 Anti-CD20 B-cell therapies in MS
10:48 CNS agents to treat MS
12:00 Evolution of risk assessment in MS
16:38 Escalation vs high efficacy approach in MS
22:40 Disease activity/progression in MS
26:59 Progression independent of relapse in MS
28:30 Patient reported outcomes and shared decision making
34:04 MS care in older patients
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Apitegromab for Spinal Muscular Atrophy
2
AAN, AHS Issue Updated Guideline on Pharmacologic Migraine Prevention in Adults: FAQs
3
AAN, AHS Issue Updated Guideline on Migraine Prevention, Atogepant Meets End Points in Phase 3 Trial, Trientine Enters Phase 3 Trial
4
CGRP-Therapy Atogepant Meets Primary and Secondary End Points in Phase 3 LUNA Trial for Menstrual Migraine
5


















